# The Development of MASLD Among Survivors of Breast or Colorectal Cancer

> **NCT07280143** · — · RECRUITING · sponsor: **University of Bern** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer Survivors
- Colorectal (Colon or Rectal) Cancer Survivors
- MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07280143
- **Lead sponsor:** University of Bern
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-14
- **Primary completion:** 2027-07-14
- **Final completion:** 2027-11-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07280143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07280143, "The Development of MASLD Among Survivors of Breast or Colorectal Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07280143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*